The Pure Global Resource Center consolidates data from over 30 global markets with local expertise, simplifying global standards to identify the most effective market entry routes.
This article was originally published on Healthcare Packaging.
Pure Global announces the launch of the Pure Global Resource Center, a one-stop platform designed to accelerate MedTech market access and streamline go-to-market strategies. Addressing the growing need for a comprehensive understanding of market opportunities and regulatory requirements, the Resource Center provides access to the latest regulatory pathways for major markets.
The Pure Global Resource Center brings together information on over 30 global markets into a single, accessible hub. This allows manufacturers to compare market access requirements easily and prioritize their strategies for market entry. The platform features a vast database of over 4 million medical device registrations and an extensive clinical trials database, offering insights into study sites, sponsors, diseases, and study stages.
“The Pure Global Resource Center combines an unparalleled level of depth and breadth of data with market insights tailored specifically for MedTech companies,” said Phyllis Meng, CEO & co-founder at Pure Global. “By combining the power of our platform with the expertise of our local market specialists, Pure Global can guide clients in identifying the most efficient and effective routes for bringing their products to the market.”
For regulatory compliance, the platform includes tools for tracking the latest regulatory changes and managing global product registrations from one location. It includes a translation platform that enables document translation into 20+ languages for efficient global communication. Additionally, AI-powered analysis of regulatory updates enhances compliance and decision-making.
The platform is highly adaptable, offering customizations to meet diverse organizational needs, from internal certification management to global product tracking. Customization options range from specific feature adjustments to full on-premises deployments.
Looking ahead, Pure Global plans to continually enhance the Resource Center based on client feedback and technological advancements, with future updates focusing on deeper integration of artificial intelligence to further address global market access challenges.
Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.
The IVDR transition includes structured processes IVD manufacturers must follow to engage with Notified Bodies. Many IVD manufacturers are interacting with Notified Bodies for the first time and must understand what is required to ensure a successful partnership. In this article, Dr. Oliver Eikenberg clarifies what manufacturers must prepare and when to engage a Notified Body for IVDR CE Marking.
Class D IVD manufacturers face fast-approaching IVDR transition deadlines, though some are more familiar with the regulatory process. In this article, Dr. Oliver Eikenberg discusses the difference between "new" and "old" Class Ds, and regulatory logistics they need to consider during the transition process.
Your IVD's intended purpose determines its classification, clinical evidence requirements, and clinical applications under the IVDR. Device companies will need a more robust intended purpose to fulfill IVDR criteria. In this article, Dr. Oliver Eikenberg explains the role of the intended purpose in IVDR compliance.
